O'Brien Greene & Co’s CVS Health CVS Stock Holding History

O'Brien Greene & Co’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4,120	Closed	-$243K	–	139
2024 Q2	$243K	Buy	4,120 +120	+3%	+$7.51K	0.08%	127
2024 Q1	$319K	Sell	4,000 -1,200	-23%	-$91.7K	0.1%	108
2023 Q4	$411K	Hold	5,200	–	–	0.14%	92
2023 Q3	$363K	Sell	5,200 -155	-3%	-$11K	0.13%	94
2023 Q2	$370K	Hold	5,355	–	–	0.13%	96
2023 Q1	$398K	Hold	5,355	–	–	0.15%	91
2022 Q4	$499K	Sell	5,355 -11,076	-67%	-$1.07M	0.19%	80
2022 Q3	$1.57M	Buy	16,431 +10,954	+200%	+$1.08M	0.21%	73
2022 Q2	$507K	Hold	5,477	–	–	0.19%	80
2022 Q1	$554K	Hold	5,477	–	–	0.18%	79
2021 Q4	$565K	Buy	5,477 +122	+2%	+$11.3K	0.19%	78
2021 Q3	$454K	Buy	5,355 +80	+2%	+$6.7K	0.17%	91
2021 Q2	$440K	Buy	5,275 +275	+6%	+$22.5K	0.16%	93
2021 Q1	$376K	Buy	+5,000	New	+$364K	0.15%	94

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

O'Brien Greene & Co's CVS Position: Q3 2024 in Review

O'Brien Greene & Co sold out of CVS Health (CVS) in Q3 2024, closing a stake of 4,120 shares — an estimated $243K sold.

O'Brien Greene & Co first reported a position in CVS in Q1 2021 and held it in 14 quarters. The position peaked at $1.57M in Q3 2022. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

O'Brien Greene & Co reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
O'Brien Greene & Co sold 4,120 CVS Health shares in Q3 2024, an estimated $243K.
O'Brien Greene & Co first reported a position in CVS Health in Q1 2021 and held it in 14 quarters.
O'Brien Greene & Co's CVS Health position peaked at $1.57M in Q3 2022.
1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on O'Brien Greene & Co's 13F filing for Q3 2024, filed 15 Nov 2024.